<DOC>
	<DOC>NCT01778426</DOC>
	<brief_summary>Observational study to evaluate the long term efficacy of Spinal Cord Stimulation (SCS) over 2 years following SCS implant. This study is requested by French Health Authorities for reimbursement renewal, to maintain reimbursement for SCS in approved indication in France.</brief_summary>
	<brief_title>Post-reimbursement Study to Follow Spinal Neurostimulator Devices for Pain Therapy (French SCS Registry)</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Patient indicated for Spinal Cord Stimulation (pain therapy) Patient implanted for less than 3 months or hospitalized for the implant of a Medtronic neurostimulator including: primary implant with Spinal Cord Stimulation indication and positive test of stimulation or device replacement of a Medtronic neurostimulator used for Pain Therapy Evaluation of usual pain in the back, upper and lower limbs using a visual analogic scale must be available for the 3 days preceding implant. Treatments must also be available Patient read and signed the data release form Patient declined participation Patient is not available for follow up Stimulation of other body part than spinal</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Chronic neuropathic pain syndrome</keyword>
	<keyword>Spinal Cord Stimulation</keyword>
	<keyword>Painstim devices</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
</DOC>